Free Trial
NASDAQ:CBIO

Crescent Biopharma 8/17/2023 Earnings Report

Crescent Biopharma logo
$11.84 -0.16 (-1.33%)
As of 04:00 PM Eastern

Crescent Biopharma EPS Results

Actual EPS
-$7.00
Consensus EPS
-$7.00
Beat/Miss
Met Expectations
One Year Ago EPS
N/A

Crescent Biopharma Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Crescent Biopharma Announcement Details

Quarter
Time
Q2 2023 Earnings Release
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Crescent Biopharma Earnings Headlines

Crescent Biopharma: Q2 Earnings Snapshot
[Shocking New Report] U.S. Dollar To Crash?
The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…
See More Crescent Biopharma Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Crescent Biopharma? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Crescent Biopharma and other key companies, straight to your email.

About Crescent Biopharma

Crescent Biopharma (NASDAQ:CBIO) operates as a biopharmaceutical company that develops and designs small molecule therapeutics to treat cancers. The company was founded on September 19, 2024 and is headquartered in Waltham, MA.

View Crescent Biopharma Profile

More Earnings Resources from MarketBeat